Cargando…

Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage

Policy makers in countries, aiming to build and expand their healthcare systems and coverage, need effective procedures to support the most efficient use of limited financial resources. Tendering is commonly deployed to minimize and fix the purchasing price for the contract duration, especially for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maniadakis, Nikolaos, Holtorf, Anke-Peggy, Otávio Corrêa, José, Gialama, Fotini, Wijaya, Kalman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132432/ https://www.ncbi.nlm.nih.gov/pubmed/29987759 http://dx.doi.org/10.1007/s40258-018-0405-7

Ejemplares similares

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018)

Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia
por: Reyes-Travé, Anna, et al.
Publicado: (2021)

Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand
por: Holtorf, Anke-Peggy, et al.
Publicado: (2021)

Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status
por: Maniadakis, N., et al.
Publicado: (2017)

Analyzing the Financial Sustainability of User Fee Removal Policies: A Rapid First Assessment Methodology with a Practical Application for Burkina Faso
por: Mathonnat, Jacky, et al.
Publicado: (2019)

Incorporating Observational Data into the Formulary Decision-Making Process--Summary of a Roundtable Discussion
por: Holtorf, Anke-Peggy
Publicado: (2008)

Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait
por: Abdullah, Ali Hadi, et al.
Publicado: (2019)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
por: Petrou, Stavros, et al.
Publicado: (2015)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

A training paradigm to enhance performance and safe use of an innovative neuroendovascular device
por: Ricci, Donald R., et al.
Publicado: (2016)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
por: Whitehurst, David G. T., et al.
Publicado: (2018)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
por: Shen, Jing, et al.
Publicado: (2018)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)
por: de Wit, Maarten, et al.
Publicado: (2016)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

Balanced assessment systems revisited
por: Dankó, Dávid, et al.
Publicado: (2017)

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research
por: Kandiyali, Rebecca, et al.
Publicado: (2018)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

Involving Patients in Health Economics Research: “The PACTS Principles”
por: Hawton, Annie, et al.
Publicado: (2020)

Telehealth and Nutrition Support During the COVID-19 Pandemic
por: Mehta, Pooja, et al.
Publicado: (2020)

Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic
por: Day, Alice S., et al.
Publicado: (2021)

Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19
por: Soofi, Moslem, et al.
Publicado: (2020)

Patient and Public Involvement (PPI) in Health Economics Methodology Research: Reflections and Recommendations
por: Al-Janabi, Hareth, et al.
Publicado: (2020)

Advancing Nutrition and Dietetics Practice: Dealing With Ethical Issues of Nutrition and Hydration
por: Schwartz, Denise Baird, et al.
Publicado: (2020)

Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers
por: Gidwani, Risha, et al.
Publicado: (2020)

Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project
por: Jansen, Jeroen P., et al.
Publicado: (2019)

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
por: Kent, Seamus, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hfdasehargi1551787dcv5cu72